Keryx Biopharmaceuticals, Inc.
(NASDAQ : KERX)

( )
KERX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.67%176.001.2%$592.87m
CELGCelgene Corporation
0.00%89.201.2%$509.00m
BIIBBiogen Inc.
1.05%272.281.2%$467.20m
GILDGilead Sciences, Inc.
0.04%73.280.9%$411.00m
INCYIncyte Corporation
0.00%62.992.5%$245.54m
REGNRegeneron Pharmaceuticals, Inc.
0.00%316.172.7%$243.99m
VRTXVertex Pharmaceuticals Incorporated
-1.28%153.161.9%$217.79m
ALXNAlexion Pharmaceuticals, Inc.
6.63%113.072.0%$213.75m
ILMNIllumina, Inc.
0.00%231.193.5%$196.58m
NKTRNektar Therapeutics
0.15%82.716.0%$194.70m
AAgilent Technologies, Inc.
0.00%65.811.5%$162.73m
ALNYAlnylam Pharmaceuticals, Inc
0.00%94.339.8%$134.72m
BLUEBluebird Bio, Inc.
0.00%162.6015.8%$118.46m
EXASExact Sciences Corporation
1.17%45.8025.7%$111.25m
BMRNBioMarin Pharmaceutical Inc.
-1.88%80.004.4%$99.58m

Company Profile

Keryx Biopharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of renal disease. Its products include phosphate-binding medicines, intravenous iron, and other medications. The company was founded in October 1998 and is headquartered in Boston, MA.